Acquired Factor X Deficiency research hub

A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis

This study is testing a new treatment called Coagadex for people with a rare bleeding disorder called acquired Factor X deficiency (aFXD), which is linked to AL amyloidosis. It aims to see if Coagadex can safely and effectively stop bleeding and help during surgery.